Introduction: A New Frontier in Pediatric Spine Surgery

Pediatric spinal conditions—from congenital scoliosis to traumatic fractures—present unique challenges that extend far beyond the mechanics of fixation. A child’s skeleton is actively growing, remodeling, and adapting, which means any implanted hardware must not interfere with natural development. Traditional metal implants (titanium, stainless steel) provide robust stabilization but often require a second surgical procedure for removal once healing is complete. This second surgery increases the cumulative risk of infection, anesthesia complications, and psychological trauma for young patients. Bioresorbable spinal implants offer a compelling alternative: they provide temporary structural support and then gradually dissolve, leaving behind only the patient’s own healed tissue. This article explores the science, clinical promise, and remaining hurdles of bioresorbable technology in pediatric spinal care, framing it as a potential paradigm shift rather than a simple material substitution.

Understanding Bioresorbable Spinal Implants

Material Composition and Mechanism of Action

Bioresorbable implants are manufactured from polymers such as poly-L-lactic acid (PLLA), poly-D,L-lactic acid (PDLLA), and poly(lactic-co-glycolic acid) (PLGA), or from degradable metals like magnesium alloys. These materials are biocompatible—meaning they do not elicit a chronic foreign-body response—and are designed to lose mechanical strength progressively as the surrounding bone or soft tissue heals. The degradation process occurs primarily through hydrolysis: water molecules cleave the polymer chains into lactic acid, which enters normal metabolic pathways and is eventually excreted as carbon dioxide and water. For magnesium alloys, corrosion produces magnesium ions that are safely absorbed by the body. The timeline of resorption can be tailored by adjusting the molecular weight, crystallinity, and copolymer ratio, allowing surgeons to match implant durability to the expected healing window—typically six to twenty-four months in pediatric spines.

Historical Context and Evolution

The concept of biodegradable implants is not new; bioresorbable sutures, pins, and screws have been used in orthopedic and craniofacial surgery for decades. However, application to the spine lagged behind due to the high mechanical demands of load-bearing axial structures. Early attempts in the 1990s used pure PLLA screws for anterior cervical discectomy and fusion, but reports of late inflammatory reactions and insufficient strength limited adoption. The current generation of bioresorbable spinal implants benefits from improved polymer processing, composite reinforcements (e.g., hydroxyapatite particles), and advanced metal alloy formulations. In pediatric patients, where lower body weight and greater remodeling capacity exist, these implants may finally achieve the balance between strength and safe degradation that has been elusive in adult spine surgery.

Advantages for Pediatric Patients

Elimination of a Second Surgery

Perhaps the most direct benefit of bioresorbable implants is the avoidance of hardware removal surgery. For children with growing spines, the need to take out metal rods or screws after spinal fusion is almost routine—estimated at 10–20% of adolescent idiopathic scoliosis cases, and higher in younger patients. A bioresorbable construct dissolves on its own, sparing the child an additional hospital stay, anesthetic exposure, and recovery period. This not only reduces healthcare costs but also lowers the cumulative emotional burden on families.

Accommodation of Spinal Growth

Unlike rigid metallic implants that can tether or restrict growth, bioresorbable materials gradually transfer load back to the maturing bone. As the implant resorbs, the spine is free to elongate and remodel without the constraint of permanent screws or plates. This is particularly valuable in very young children with conditions such as congenital kyphosis or early-onset scoliosis, where growth-friendly techniques (e.g., growing rods, VEPTR) have traditionally required repeated lengthening surgeries. A bioresorbable scaffold could provide temporary stabilization while allowing natural growth to occur unimpeded.

Chronic metallic implants can serve as a nidus for bacterial colonization, particularly in pediatric patients with compromised immune systems or wound healing issues. Because bioresorbable implants are not permanent, the risk of late implant-associated infection is theoretically lower. Furthermore, the gradual dissolution eliminates the possibility of late hardware failure, screw pullout, or rod breakage that might necessitate emergent revision. Stress shielding—a phenomenon where stiff metal implants absorb most of the mechanical load, causing underlying bone to weaken—is also mitigated because the implant’s stiffness decreases over time, sharing the load with the healing spine.

Improved Imaging Compatibility

Metal implants produce imaging artifacts on CT and MRI scans, obscuring visualization of surrounding bone and soft tissues. Bioresorbable polymers and magnesium alloys cause far fewer artifacts, enabling clearer postoperative assessment of fusion masses, adjacent discs, and neural elements. This is especially beneficial in pediatric patients who may require lifelong imaging surveillance for conditions such as syringomyelia or spinal cord tethering.

Clinical Applications in Pediatric Spinal Conditions

Scoliosis (Adolescent Idiopathic and Early-Onset)

The most widely studied application of bioresorbable spinal implants is in posterior spinal fusion for scoliosis. In adolescent idiopathic scoliosis (AIS), metallic screws and rods are the standard, but removal rates are significant. Pilot studies using bioresorbable pedicle screws and rods made of PLLA have shown comparable deformity correction and maintenance at two-year follow-up, with the added benefit of progressive implant resorption. For early-onset scoliosis (EOS), where growth preservation is paramount, bioresorbable growing rods or tethers could theoretically reduce the number of required lengthening procedures. However, clinical evidence remains limited to small case series, and larger trials are needed.

Congenital Spinal Deformities

Infants and toddlers with hemivertebrae, unilateral bars, or segmentation anomalies often require early surgical intervention to prevent progressive deformity. Bioresorbable implants used for hemivertebra excision and short-segment fusion may allow the adjacent normal motion segments to continue growing, reducing the risk of adjacent segment disease and the need for future extension of the fusion. Additionally, the resorption of hardware avoids the long-term presence of metal in a growing, remodeling spine.

Traumatic Fractures and Dislocations

Pediatric spinal trauma—often resulting from motor vehicle accidents, falls, or sports injuries—can involve vertebral body compression fractures, Chance fractures, or ligamentous disruption. While most stable fractures can be managed nonoperatively, unstable injuries require instrumentation. Bioresorbable screws and plates have been used for anterior cervical corpectomy and discectomy in children, though data are sparse. The promise lies in providing sufficient stability during the 8–16 week healing period while eliminating the need for later removal. Magnesium-based screws, which offer higher initial strength than polymers, are particularly attractive for load-sharing applications in the lumbar spine.

Spinal Tumors and Infection

In cases of vertebral column resection for primary bone tumors (e.g., osteosarcoma, Ewing sarcoma) or infectious conditions (e.g., vertebral osteomyelitis, discitis), temporary stabilization is often required. Bioresorbable implants could be used to reconstruct the anterior column after corpectomy, providing support for bone graft incorporation without leaving permanent hardware. The absence of metallic artifacts also improves postoperative surveillance imaging for tumor recurrence or infection resolution.

Current Challenges and Limitations

Insufficient Mechanical Strength

The most significant technical hurdle is that current bioresorbable materials, particularly polymers, have lower initial strength and stiffness compared to titanium or stainless steel. In large, rigid pediatric spines or in patients with high body mass, the implant may deform or fail before bone fusion is complete. Magnesium alloys have greater strength but are more susceptible to rapid corrosion in the acidic environment of the healing spine, potentially releasing gas bubbles and causing local inflammation. Engineers are exploring composite materials, surface treatments, and controlled degradation profiles to address these issues.

Controlling the Degradation Rate

The ideal bioresorbable implant should maintain mechanical integrity for a predictable period—long enough for solid fusion (usually 9–12 months) but not so long that it delays physiologic load transfer. However, degradation rates are influenced by implant size, polymer crystallinity, local pH, and biological activity. In pediatric patients, whose metabolism is faster and whose healing dynamics differ from adults, this calibration is even more challenging. Rapid degradation can lead to early loss of fixation, while extremely slow resorption negates the advantage of avoiding removal. Advanced modeling and personalized material selection may help, but remain investigational.

Inflammatory and Foreign-Body Responses

Although bioresorbable materials are generally well tolerated, the breakdown products (lactic acid, magnesium ions) can trigger a foreign-body granulomatous reaction. In pediatric patients, this manifests as sterile serous drainage, osteolysis, or soft-tissue swelling. Aseptic inflammatory reactions have been reported in 5–15% of cases with earlier PLLA implants, particularly in highly crystalline formulations. The development of amorphous or low-crystallinity polymers, as well as coatings that modulate the immune response, aims to minimize this complication.

Cost and Regulatory Hurdles

Bioresorbable implants are typically more expensive than their metallic counterparts—sometimes three to five times the cost per unit. For hospital systems and insurance providers, the upfront expense must be weighed against the potential savings from avoiding removal surgery and lower revision rates. Regulatory approval pathways (FDA 510(k) clearance vs. premarket approval) for novel materials and designs can be lengthy, limiting the availability of advanced constructs. In pediatric populations, the need to demonstrate safety and efficacy in growing skeletons adds further complexity to clinical trials.

Current Research and Future Directions

Advanced Polymer Composites and Bioactive Coatings

Researchers are embedding bioactive ceramics such as hydroxyapatite (HA) or beta-tricalcium phosphate (β-TCP) into polymer matrices to improve osteoconductivity and mechanical strength. These composites not only reinforce the implant but also release calcium and phosphate ions that enhance bone formation. Another promising avenue is the application of bioactive coatings—such as type I collagen, bone morphogenetic protein-2 (BMP-2), or antimicrobial agents—to the implant surface. Coatings can accelerate fusion, reduce infection risk, and modulate the degradation microenvironment.

3D-Printed Personalized Implants

The advent of 3D printing allows the fabrication of patient-specific bioresorbable implants based on preoperative CT or MRI scans. For pediatric spinal deformities, a custom-designed screw, interbody cage, or growing rod can perfectly match the child’s anatomy, optimizing screw trajectory and minimizing inadvertent violation of the spinal canal or pedicles. 3D printing also permits the creation of porous architectures that promote bone ingrowth and controlled degradation. Early case reports of 3D-printed bioresorbable spinal implants in children have shown encouraging results, though the technology remains at the proof-of-concept stage.

Combination with Biologics and Stem Cells

The potential synergy between bioresorbable scaffolds and biologic therapies is a vibrant research frontier. A bioresorbable implant can serve as a delivery vehicle for osteogenic cells (e.g., mesenchymal stem cells), growth factors (e.g., BMP-2, VEGF), or gene therapy vectors. By releasing these agents in a controlled manner over several weeks, the implant could actively stimulate bone regeneration and accelerate fusion. In pediatric patients who may not tolerate the side effects of high-dose BMP-2 (such as heterotopic ossification), a localized, slow-release system could be safer and more effective.

Smart Implants with Embedded Sensors

Emerging research incorporates tiny sensors into bioresorbable implants to monitor the healing process in real time. These sensors could measure strain, temperature, pH, or the presence of infectious markers, transmitting data wirelessly to an external reader. Once healing is complete, the sensors degrade along with the implant, leaving no foreign material behind. For pediatric spine surgeons, such feedback could guide decisions about activity restrictions, brace weaning, or the need for intervention—all without exposing the child to radiation from repeated imaging.

Comparison with Traditional Metallic Implants

To contextualize the potential of bioresorbable implants, it is useful to contrast them with the current standard of care:

  • Mechanical Strength: Metal implants offer superior initial strength and stiffness. Bioresorbable polymers are weaker; magnesium alloys approach metal strength but degrade faster.
  • Need for Removal: Metal often requires a second surgery; bioresorbable eliminates it.
  • Growth Compatibility: Metal can restrict growth; bioresorbable allows gradual load transfer and does not tether growth.
  • Infection Risk: Both carry initial infection risk, but metal retains a permanent surface for biofilm formation; bioresorbable may lower late infection risk.
  • Imaging Artifacts: Metal causes significant CT/MRI artifacts; bioresorbable produces minimal artifacts.
  • Cost: Bioresorbable implants are more expensive upfront, but may be cost-saving when factoring in avoidance of removal surgery.
  • Regulatory Track Record: Metal implants have decades of evidence; bioresorbable spine implants have limited long-term pediatric data.

Conclusion

Bioresorbable spinal implants represent a profound evolution in the surgical management of pediatric spinal conditions. By offering temporary stabilization that yields to the child’s own growing anatomy, they address many of the shortcomings of permanent metal hardware—avoiding repeat surgery, reducing stress shielding, enabling better imaging, and potentially lowering long-term complication rates. The technology is not yet mature; challenges around mechanical strength, controlled degradation, inflammatory responses, and cost must be overcome before bioresorbable implants become the standard of care. However, the pace of innovation in polymer chemistry, 3D printing, and biologics is accelerating, and early clinical results are promising. For the youngest patients, who face a lifetime of potential spinal issues, the ability to operate with materials that heal alongside them is more than a convenience—it is a fundamental shift toward more physiological, patient-centered care. Continued research and collaborative efforts between engineers, surgeons, and regulatory bodies will be essential to bring this potential to full clinical fruition.